Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) rose 3.9% during mid-day trading on Thursday . The stock traded as high as $1.35 and last traded at $1.34. Approximately 13,880,792 shares changed hands during trading, a decline of 46% from the average daily volume of 25,475,352 shares. The stock had previously closed at $1.29.
Analysts Set New Price Targets
Separately, Roth Mkm cut their target price on Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research note on Friday, October 11th.
View Our Latest Stock Report on TLRY
Tilray Price Performance
The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. The stock has a 50 day moving average price of $1.62 and a two-hundred day moving average price of $1.75. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of -4.96 and a beta of 2.14.
Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The firm had revenue of $200.00 million during the quarter, compared to analysts' expectations of $218.70 million. During the same period in the previous year, the firm posted ($0.10) EPS. Tilray's revenue for the quarter was up 13.0% on a year-over-year basis. As a group, analysts expect that Tilray Inc will post -0.14 EPS for the current year.
Insider Buying and Selling
In related news, CFO Carl A. Merton bought 26,000 shares of the stock in a transaction that occurred on Friday, November 15th. The stock was purchased at an average cost of $1.36 per share, with a total value of $35,360.00. Following the purchase, the chief financial officer now directly owns 26,000 shares of the company's stock, valued at $35,360. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 0.87% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of TLRY. Bank of Montreal Can lifted its holdings in Tilray by 19.6% during the 2nd quarter. Bank of Montreal Can now owns 2,169,100 shares of the company's stock worth $3,622,000 after buying an additional 355,778 shares during the last quarter. Lazard Asset Management LLC purchased a new stake in Tilray during the 1st quarter valued at approximately $118,000. Avantax Advisory Services Inc. grew its holdings in shares of Tilray by 46.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company's stock worth $131,000 after acquiring an additional 16,792 shares during the period. Creative Planning lifted its stake in Tilray by 36.6% in the 3rd quarter. Creative Planning now owns 141,921 shares of the company's stock valued at $250,000 after buying an additional 38,054 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in shares of Tilray by 11.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 682,478 shares of the company's stock worth $1,131,000 after buying an additional 70,605 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
